Veterinary Oncology Market Projected to Surpass USD 819.84 Million by 2030

As per the report published by Allied Market Research, the global veterinary oncology market was accounted for $297.30 million in 2020, and is estimated to garner $819.84 million by 2030, growing at a CAGR of 10.8% from 2021 to 2030.

Rise in prevalence of cancer in animals, surge in R&D activities for veterinary cancer therapy, growth in veterinary healthcare expenditure, and development in pet insurance policy drive the growth of the global veterinary oncology market. However, high cost of therapies for the treatment of veterinary oncology hinders the market growth. On the contrary, surge in number of veterinary clinical trial studies is expected to open new opportunities for the market players in the future.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭-https://www.alliedmarketresearch.com/request-sample/7504

𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐂𝐨𝐯𝐢𝐝-19 𝐨𝐧 𝐕𝐞𝐭𝐞𝐫𝐢𝐧𝐚𝐫𝐲 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭-

The Covid-19 pandemic had a negative impact on the market due to tremendous stress on the healthcare system across the world and rise in need for development of diagnostic instruments & treatment centers for humans.
However, there has been rise in demand for pets for companionship during the pandemic, which positively affected the market.

The report divides the global veterinary oncology market on the basis of therapy, animal, cancer, and region.

Based on therapy, the chemotherapy segment held the largest share in 2020, accounting for more than one-fourth of the market. Moreover, the segment is projected to manifest the highest CAGR of 11.5% during the forecast period. The report includes an analysis of segments such as surgery, radiology, and others.

On the basis of animal, the canine segment held the lion's share in 2020, contributing to nearly three-fifths of the market. However, the segment is estimated to portray the highest CAGR of 11.1% from 2021 to 2030. The report includes analysis of the feline segment.

The report offers an analysis of the global veterinary oncology market across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the lion's share in 2020, accounting for more than two-fifths of the market. However, the market across Asia-Pacific is anticipated to showcase the highest CAGR of 11.9% during the forecast period.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲- https://www.alliedmarketresearch.com/purchase-enquiry/7504

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐅𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬
The study provides an in-depth analysis of the veterinary oncology market, and the current trends & future estimations to elucidate imminent investment pockets.
It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing veterinary oncology market opportunities.
Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the veterinary oncology market.

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
By therapy, the chemotherapy segment was the highest contributor to the market in 2020.
On the basis of animal type, the canine segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
Depending on cancer, the lymphoma segment was the highest contributor to the market in 2020.
Region wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞- https://www.alliedmarketresearch.com/veterinary-oncology-market-A07139

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲-
𝐀𝐑 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/ar-in-healthcare-market-A06051

𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐌𝐲𝐞𝐥𝐨𝐦𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/multiple-myeloma-market

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.